Mucormycosis in covid-19 disease- a systematic review of the literature

AUTHOR(s) : Majumder P, Singh A
DOI No. : 0.31741/ijhrmlp.v8.i1.2022.10


Background and aims: There has been a recent significant rise in the incidence of Mucormycosis associated with Covid-19 diseases in India, leading to an increase in disease burden of associated morbidity and mortality on the patients and the health systems. The present study is a comprehensive review of literature summarising the patient demographics, initial presentation, diagnosis, clinical categorization, risk factors, treatment methods, and overall mortality related to Covid-19 associated Mucormycosisreported in published literature. Materials and methods: PubMed database was searched, and 68 patients from 23 published articles were included and reported according to the PRISMA guidelines. A descriptive summary of the different variables related to Covid-19 associated Mucormycosis was reported. Conclusion: Rhino orbito cerebral Mucormycosis was the most common clinical presentation identified in Covid-19 disease, while diabetes mellitus with or without ketoacidosis and corticosteroid use remained the most common risk factor. The risk of developing rhino orbito cerebral Mucormycosis was significantly higher in diabetic Covid-19 patients. Mortality was higher in patients treated with antifungal drugs only compared to the antifungal drug plus surgery group.

Keywords: Covid-19 disease; Mucormycosis; Systematic review.

Registered Office Address:
House No: One, Karmabir Bordoloi Path, Wireless,
Rukmini Nagar, Dispur-06, Assam, India

Mobile: 09435017802
IJHRMLP is an open-access journal, and the articles published are instantly available to read and use again. The published articles thus can be downloaded, shared, and reused without restriction if the contributing original authors are appropriately cited. Author(s) retain the copyright of their article, with articles licensed to AHRME and the journal following the Creative Commons Attribution License (CC-BY).
Maintain By Prism Infosys